Patrick Budny
Montgomery, ALNPI 1790744654
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 200 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 62.8% of it on its own, with 15 other manufacturers making up the rest.
Across 200 payments — averaging $29.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Sientra, Inc.$399
- Merz North America, Inc.$391
- Mentor Worldwide LLC$372
- Motiva USA, LLC$305
- Integra Lifesciences Corporation$208
- plus $541 from 10 others
Across 2 payments — averaging $750.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sientra, Inc.$2K
What the payments were for
- Food & beverage$5,949100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 139 | $3,734 |
| Sientra, Inc. | 8 | $399 |
| Merz North America, Inc. | 7 | $391 |
| Mentor Worldwide LLC | 21 | $372 |
| Motiva USA, LLC | 4 | $305 |
| Integra Lifesciences Corporation | 4 | $208 |
| TELA Bio, Inc. | 3 | $182 |
| Regeneron Healthcare Solutions, Inc. | 4 | $113 |
| Galderma Laboratories, L.p. | 2 | $103 |
| Vertex | 2 | $44 |
| BD | 1 | $25 |
| TEI Biosciences Inc | 1 | $17 |
| Heron Therapeutics, Inc. | 1 | $17 |
| Avanos Medical | 1 | $15 |
| Medline Industries LP | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 16 | $139 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $107 |
| Promethazine Hcl | 15 | $34 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.